Compare CYRX & SENS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CYRX | SENS |
|---|---|---|
| Founded | 1999 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 472.7M | 252.5M |
| IPO Year | N/A | N/A |
| Metric | CYRX | SENS |
|---|---|---|
| Price | $9.41 | $6.20 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 9 | 6 |
| Target Price | $12.83 | ★ $25.58 |
| AVG Volume (30 Days) | ★ 595.8K | 370.3K |
| Earning Date | 11-04-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 1.27 | N/A |
| Revenue | ★ $243,795,000.00 | $29,298,000.00 |
| Revenue This Year | N/A | $59.55 |
| Revenue Next Year | $9.26 | $70.49 |
| P/E Ratio | $7.45 | ★ N/A |
| Revenue Growth | ★ 41.27 | 31.94 |
| 52 Week Low | $4.58 | $5.25 |
| 52 Week High | $11.44 | $28.00 |
| Indicator | CYRX | SENS |
|---|---|---|
| Relative Strength Index (RSI) | 50.66 | 49.91 |
| Support Level | $9.08 | $6.02 |
| Resistance Level | $9.67 | $6.95 |
| Average True Range (ATR) | 0.44 | 0.40 |
| MACD | -0.03 | -0.12 |
| Stochastic Oscillator | 28.15 | 28.78 |
CryoPort Inc is a leader serving the life sciences industry as a provider of integrated temperature-controlled supply chain solutions supporting the life sciences in the biopharma/pharma, animal health, and reproductive medicine markets. It operates in two reportable segments: Life Sciences Services and Life Sciences Products. Geographically the company operates in the Americas, Europe, the Middle East and Africa (EMEA), and Asia Pacific (APAC), generating a majority of its revenue from the Americas.
Senseonics Holdings Inc is a medical technology company. It is focused on the design, development, and commercialization of glucose monitoring system, which helps people to manage their diabetes community with differentiated, long-term implantable glucose management technology. Its products and services include a Continuous glucose monitoring system, Sensor, Smart transmitter, and Mobile app. The firm has a Glucose monitoring product segment. The majority of the revenue is generated outside of the United States.